Biocon has reported results for fourth quarter ended March 31, 2012.
On the standalone basis, the company has posted a fall of 29.18% in its net profit at Rs 62.34 crore for the quarter ended March 31, 2012 as compared to Rs 88.03 crore for the same quarter in the previous year. However total income has increased by 14.40% at Rs 432.60 crore for quarter under review as compared to Rs 378.15 crore for the quarter ended March 31, 2011
On the consolidated basis, the company has posted a fall of 2.99% in its net profit at Rs 97.80 crore for the quarter ended March 31, 2012 as compared to Rs 100.81 crore for the same quarter in the previous year. However total income has increased by 29.60% at Rs 610.20 crore for quarter under review as compared to Rs 470.85 crore for the quarter ended March 31, 2011
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1849.05 |
Dr. Reddys Lab | 1274.25 |
Cipla | 1553.20 |
Lupin | 2184.00 |
Zydus Lifesciences | 1001.85 |
View more.. |